News tagged with pharmaceutical
Japanese firm buys US pharmaceutical company
(AP)—A Japanese pharmaceutical company is acquiring LigoCyte Pharmaceuticals in a $60 million deal to expand its vaccine division, Takeda Pharmaceutical Co. announced.
Medications
Oct 05, 2012 |
not rated yet |
0
Limiting the problem of missing data urged for clinical trials
(HealthDay)—Data missing from clinical trials can undermine the credibility of those trials, and little attention has been focused on this issue until recently, experts say.
Medical research
Oct 04, 2012 |
not rated yet |
0
US says Teva antidepressant is ineffective
(AP)—Teva Pharmaceuticals has stopped shipping its generic version of a popular antidepressant off the market after a U.S. government analysis showed the pill does not work properly.
Medications
Oct 03, 2012 |
5 / 5 (1) |
0
Biological markers increase clinical trial success rate of new breast cancer drugs
Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research ...
Cancer
Oct 01, 2012 |
not rated yet |
0
MRI images transplanted islet cells with help of positively charged nanoparticles
In a study to investigate the detection by MRI of six kinds of positively-charged magnetic iron oxide nanoparticles designed to help monitor transplanted islet cells, a team of Japanese researchers found that the charged ...
Medical research
Oct 01, 2012 |
not rated yet |
0
Choice of psoriasis treatment affects CVD event rates
(HealthDay)—Compared with other anti-psoriatic therapies, systemic anti-inflammatory treatment of patients with severe psoriasis with biologic agents or methotrexate is associated with a lower combined ...
Immunology
Sep 27, 2012 |
not rated yet |
0
An old drug finds a new use
Dr. Anglea Wandinger-Ness and Dr. Laurie Hudson were awarded a Provocative Questions grant to investigate the use of R-ketorolac against ovarian cancer. Ketorolac is an NSAID that the FDA approved for human use in 1991. They ...
Medications
Sep 27, 2012 |
not rated yet |
0
Short-, long-course therapy comparable in T3 rectal cancer
(HealthDay)—There are no statistically significant differences in the rates of local recurrence (LR), distant recurrence, relapse-free survival, overall survival, or late toxicity in patients treated with ...
Cancer
Sep 27, 2012 |
not rated yet |
0
Public Citizen: State drug fraud cases on the rise
(AP)—A consumer advocacy group is reporting that pharmaceutical companies have paid more than $30 billion to state and federal governments to settle allegations of fraud over the last 20 years.
Medications
Sep 27, 2012 |
not rated yet |
0
Bayer 'disappointed' after losing India patent fight
Pharmaceutical giant Bayer AG on Wednesday said it was "disappointed" with an Indian ruling that allows a local firm to produce a cheaper copy of its patented drug Nexavar for liver and lung cancer.
Medications
Sep 26, 2012 |
not rated yet |
0
Watch-and-wait OK in low-tumor burden follicular lymphoma
(HealthDay)—An initial watch-and-wait strategy does not have a detrimental effect on the freedom from treatment failure (FFTF) or overall survival rate in selected patients with low-tumor burden follicular ...
Cancer
Sep 26, 2012 |
5 / 5 (1) |
0
Patient preference doesn't affect chemo in advanced CRC
(HealthDay)—For patients with metastatic colorectal cancer (mCRC), most patients are treated with chemotherapy, even if they express negative or marginal preferences, according to a study published online ...
Cancer
Sep 21, 2012 |
not rated yet |
0
Sequential oral, topical tacrolimus benefits dermatitis
(HealthDay)—Sequential therapy with oral tacrolimus and topical tacrolimus may be an effective treatment for severe atopic dermatitis (AD), according to a pilot study published in the October issue of the ...
Diseases, Conditions, Syndromes
Sep 20, 2012 |
not rated yet |
0
New guidelines issued for pediatric fever and neutropenia
(HealthDay)—New evidence-based guidelines have been compiled on the management of fever and and neutropenia (FN) in children with cancer and/or who are undergoing hematopoietic stem-cell transplantation; ...
Cancer
Sep 19, 2012 |
not rated yet |
0
Can disclosure hurt the translation of research?
All major clinical trials now include disclosures detailing who funded the study to ensure transparency. However, is it possible that this transparency is actually hurting research? One might assume that the methodological ...
Other
Sep 19, 2012 |
not rated yet |
0
|
